QT Imaging Holdings, Inc. is a medical imaging company focused on transforming breast health through safer, accessible, and more informative diagnostic technology. Its platform combines Quantitative Transmission (QT) ultrasound, artificial intelligence, and tissue biomarkers to support earlier and more accurate care. The company’s FDA-cleared QTI Breast Acoustic CT Scanner produces high-resolution, three-dimensional breast images without ionizing radiation or compression. Its technology also includes image-reconstruction software, AI-powered lesion classification, tissue biomarkers derived from speed-of-sound maps, and cloud-based image analytics and reporting.

QT Imaging presents its system as an alternative or complement to conventional breast imaging, with potential value for women with dense breast tissue, patients unable to undergo MRI, and settings with limited access to specialized imaging facilities. The company highlights applications including screening, diagnostic assessment, growth monitoring, and reducing unnecessary follow-up procedures. Its product offering includes the scanner and QTviewer software, supported by clinical studies, research publications, reimbursement resources, and information on FDA clearances.